REPLIGEN CORP - COMMON STOCK (RGEN)

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
52,045,384
Share change
+2,209,003
Total reported value
$8,811,980,100
Put/Call ratio
43%
Price per share
$169.31
Number of holders
429
Value change
+$355,886,906
Number of buys
208
Number of sells
191

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2022

As of 31 Dec 2022, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 429 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,045,384 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, SANDS CAPITAL MANAGEMENT, LLC, WCM INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, Invesco Ltd., BROWN CAPITAL MANAGEMENT LLC, Artisan Partners Limited Partnership, and MACQUARIE GROUP LTD. This page lists 433 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.